glp 1 agonist for weight loss GLP-1 Agonists: A Comprehensive Overview Top GLP-1 Agonists Balance Weight

1995;310(Pt 1):203214

GLP-1 RAs have also demonstrated cardioprotective effects by reducing the risk of major cardiovascular events, such as heart attacks and strokes, in individuals with T2DM

Cho MR, Lee S, Song SK

These findings are concordant with those of observational studies that have also observed a decreased risk of major adverse cardiovascular events when comparing the GLP-1 receptor agonist-SGLT-2 inhibitor combination with different types of comparators: sulfonylurea-GLP-1 receptor agonist combination (hazard ratio 0.67, 0.59 to 0.89),30 metformin-sulfonylurea combination (hazard ratio 0.53, 0.35 to 0.80),31 and other combination regimens (odds ratio 0.70, 0.50 to 0.98).19 As these studies compared the GLP-1 receptor agonist-SGLT2 inhibitor combination with other drug combinations, they were designed to answer different clinical questions.193031 By contrast, our study was specifically designed to determine whether the add-on of a GLP-1 receptor agonist or an SGLT-2 inhibitor versus either drug class alone results in additional benefits on cardiovascular and renal outcomes

Throughout this article, any reference to Tirzepatide for weight loss refers to Zepbound